Expression of human NAA11 (ARD1B) gene is tissue-specific and is regulated by DNA methylation

References

• Yang XJ. Lysine acetylation and the bromodomain: a new partnership for signaling. Bioessays 2004; 26:1076 - 1087
   PubMed Web of Science ®Google Scholar
• Driessen HP, de Jong WW, Tesser GI, Bloemendal H. The mechanism of N-terminal acetylation of proteins. CRC Crit Rev Biochem 1985; 18:281 - 325
   PubMed Web of Science ®Google Scholar
• Starheim KK, Gromyko D, Velde R, Varhaug JE, Arnesen T. Composition and biological significance of the human Nalpha-terminal acetyltransferases. BMC Proc 2009; 3:3
   Google Scholar
• Gautschi M, Just S, Mun A, Ross S, Rucknagel P, Dubaquie Y, et al. The yeast N(alpha)-acetyltransferase NatA is quantitatively anchored to the ribosome and interacts with nascent polypeptides. Mol Cell Biol 2003; 23:7403 - 7414
   PubMed Web of Science ®Google Scholar
• Polevoda B, Brown S, Cardillo TS, Rigby S, Sherman F. Yeast N(alpha)-terminal acetyltransferases are associated with ribosomes. J Cell Biochem 2008; 103:492 - 508
   PubMed Web of Science ®Google Scholar
• Park EC, Szostak JW. ARD1 and NAT1 proteins form a complex that has N-terminal acetyltransferase activity. EMBO J 1992; 11:2087 - 2093
   PubMed Web of Science ®Google Scholar
• Arnesen T, Gromyko D, Kagabo D, Betts MJ, Starheim KK, Varhaug JE, et al. A novel human NatA Nalpha-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1). BMC Biochem 2009; 10:15
   PubMed Web of Science ®Google Scholar
• Arnesen T, Van Damme P, Polevoda B, Helsens K, Evjenth R, Colaert N, et al. Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans. Proc Natl Acad Sci USA 2009; 106:8157 - 8162
   PubMed Web of Science ®Google Scholar
• Hwang CS, Shemorry A, Varshavsky A. N-terminal acetylation of cellular proteins creates specific degradation signals. Science 327:973 - 977
   PubMed Web of Science ®Google Scholar
• Forte GMA, Pool, Martin R, Stirling, Colin J. N-Terminal Acetylation Inhibits Protein Targeting to the Endoplasmic Reticulum. PLoS Biol 2011; 9:1001073
   Web of Science ®Google Scholar
• Ohkawa N, Sugisaki S, Tokunaga E, Fujitani K, Hayasaka T, Setou M, et al. N-acetyltransferase ARD1-NAT1 regulates neuronal dendritic development. Genes Cells 2008; 13:1171 - 1183
   PubMed Web of Science ®Google Scholar
• Sugiura N, Adams SM, Corriveau RA. An evolutionarily conserved N-terminal acetyltransferase complex associated with neuronal development. J Biol Chem 2003; 278:40113 - 40120
   PubMed Web of Science ®Google Scholar
• Arnesen T, Gromyko D, Pendino F, Ryningen A, Varhaug JE, Lillehaug JR. Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex. Oncogene 2006; 25:4350 - 4360
   PubMed Web of Science ®Google Scholar
• Seo JH, Cha JH, Park JH, Jeong CH, Park ZY, Lee HS, et al. Arrest defective 1 autoacetylation is a critical step in its ability to stimulate cancer cell proliferation. Cancer Res 2010; 70:4422 - 4432
   PubMed Web of Science ®Google Scholar
• Lim JH, Park JW, Chun YS. Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation. Cancer Res 2006; 66:10677 - 10682
   PubMed Web of Science ®Google Scholar
• Yu M, Ma M, Huang C, Yang H, Lai J, Yan S, et al. Correlation of expression of human arrest-defective-1 (hARD1) protein with breast cancer. Cancer Invest 2009; 27:978 - 983
   PubMed Web of Science ®Google Scholar
• Fisher TS, Etages SD, Hayes L, Crimin K, Li B. Analysis of ARD1 function in hypoxia response using retroviral RNA interference. J Biol Chem 2005; 280:17749 - 17757
   PubMed Web of Science ®Google Scholar
• Yu M, Gong J, Ma M, Yang H, Lai J, Wu H, et al. Immunohistochemical analysis of human arrest-defective-1 expressed in cancers in vivo. Oncol Rep 2009; 21:909 - 915
   PubMed Web of Science ®Google Scholar
• Jiang B, Ren T, Dong B, Qu L, Jin G, Li J, et al. Peptide mimic isolated by autoantibody reveals human arrest defective 1 overexpression is associated with poor prognosis for colon cancer patients. Am J Pathol 2010; 177:1095 - 1103
   PubMed Web of Science ®Google Scholar
• Ren T, Jiang B, Jin G, Li J, Dong B, Zhang J, et al. Generation of novel monoclonal antibodies and their application for detecting ARD1 expression in colorectal cancer. Cancer Lett 2008; 264:83 - 92
   PubMed Web of Science ®Google Scholar
• Lee CF, Ou DS, Lee SB, Chang LH, Lin RK, Li YS, et al. hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing. J Clin Invest 2010; 120:2920 - 2930
   PubMed Web of Science ®Google Scholar
• Shin DH, Chun YS, Lee KH, Shin HW, Park JW. Arrest defective-1 controls tumor cell behavior by acetylating myosin light chain kinase. PLoS One 2009; 4:7451
   Web of Science ®Google Scholar
• Kuo HP, Lee DF, Chen CT, Liu M, Chou CK, Lee HJ, et al. ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway. Sci Signal 2010; 3:9
   PubMed Web of Science ®Google Scholar
• Arnesen T, Gromyko D, Horvli O, Fluge O, Lillehaug J, Varhaug JE. Expression of N-acetyl transferase human and human Arrest defective 1 proteins in thyroid neoplasms. Thyroid 2005; 15:1131 - 1136
   PubMed Web of Science ®Google Scholar
• Hua KT, Tan CT, Johansson G, Lee JM, Yang PW, Lu HY, et al. N-alpha-acetyltransferase 10 protein suppresses cancer cell metastasis by binding PIX proteins and inhibiting Cdc42/Rac1 activity. Cancer Cell 2011; 19:218 - 231
   PubMed Web of Science ®Google Scholar
• Pang AL, Peacock S, Johnson W, Bear DH, Rennert OM, Chan WY. Cloning, characterization and expression analysis of the novel acetyltransferase retrogene Ard1b in the mouse. Biol Reprod 2009; 81:302 - 309
   PubMed Web of Science ®Google Scholar
• Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, Bae MH, et al. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 2002; 111:709 - 720
   PubMed Web of Science ®Google Scholar
• Arnesen T, Betts MJ, Pendino F, Liberles DA, Anderson D, Caro J, et al. Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase. BMC Biochem 2006; 7:13
   PubMedGoogle Scholar
• Huang GL, Li BK, Zhang MY, Zhang HZ, Wei RR, Yuan YF, et al. LOH analysis of genes around D4S2964 identifies ARD1B as a prognostic predictor of hepatocellular carcinoma. World J Gastroenterol 2010; 16:2046 - 2054
   PubMed Web of Science ®Google Scholar
• Illingworth RS, Bird AP. CpG islands-‘a rough guide’. FEBS Lett 2009; 583:1713 - 1720
   PubMed Web of Science ®Google Scholar
• Berdasco M, Esteller M. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell 2010; 19:698 - 711
   PubMed Web of Science ®Google Scholar
• Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006; 31:89 - 97
   PubMed Web of Science ®Google Scholar
• Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010; 28:1057 - 1068
   PubMed Web of Science ®Google Scholar
• Iannello RC, Young J, Sumarsono S, Tymms MJ, Dahl HH, Gould J, et al. Regulation of Pdha-2 expression is mediated by proximal promoter sequences and CpG methylation. Mol Cell Biol 1997; 17:612 - 619
   PubMed Web of Science ®Google Scholar
• Tang H, Goldberg E. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB and CpG island methylation. J Androl 2009; 30:157 - 167
   PubMed Web of Science ®Google Scholar
• De Smet C, Lurquin C, Lethe B, Martelange V, Boon T. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 1999; 19:7327 - 7335
   PubMed Web of Science ®Google Scholar
• Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18:1427 - 1431
   PubMed Web of Science ®Google Scholar